Capone E, Lattanzio R, Gasparri F, Orsini P, Rossi C, Iacobelli V, De Laurenzi V, Natali PG, Valsasina B, Iacobelli S, Sala GL
Pharmaceutics (2021), 13(4), 483
Home / EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors
Capone E, Lattanzio R, Gasparri F, Orsini P, Rossi C, Iacobelli V, De Laurenzi V, Natali PG, Valsasina B, Iacobelli S, Sala GL
Pharmaceutics (2021), 13(4), 483
Nerviano Medical Sciences S.r.l.
Viale Luigi Pasteur 10
20014 Nerviano (MI)
Italy
Share Capital: € 1,200,000.00
fully paid-in
Company subject to the management and coordination of NMS Group S.p.A.